CoChat
Sign Up
Cited by 25

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Evaluation of Montmorillonite/Poly (L-Lactide) microcomposite spheres as ambidextrous reservoirs for controlled release of Capecitabine (Xeloda) and assessment of cell cytotoxic and oxidative stress markers

Kevadiya, Bhavesh D., Chettiar, Shiva Shankaran, Rajkumar, Shalini, Bajaj, Hari C., Brahmbhatt, Harshad, Chaudhari, Jayesh C., Thumbar, Rahul P., Jhala, Devendrasinh, Rao, Mandava V.·2014·Composites Science and Technology
DOI 10.1016/j.compscitech.2013.11.003
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.compscitech.2013.11.003

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 30

  1. Shoemaker, 2004, 5-Fluorouracil-induced coronary vasospasm, Cancer Control, 11, 46, 10.1177/107327480401100107 · DOI
  2. Diasio, 1989, Clinical pharmacology of 5-fluorouracil, Clin Pharmacokinet, 16, 215, 10.2165/00003088-198916040-00002 · DOI
  3. Kevadiya, 2012, Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU), Eur J Pharm Biopharm, 81, 91, 10.1016/j.ejpb.2012.01.004 · DOI
  4. Jin, 2010, Preparation of 5-fluorouracil/β-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties, Ind Eng Chem Res, 49, 11176, 10.1021/ie100990z · DOI
  5. Ishikawa, 1998, Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts, Biochem Pharmacol, 55, 1091, 10.1016/S0006-2952(97)00682-5 · DOI
  6. Miwa, 1998, Design of a novel oral fluoropyrimidine carbamate, apecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue, Eur J Cancer, 34, 1274, 10.1016/S0959-8049(98)00058-6 · DOI
  7. Schuller, 2000, Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients, Cancer Chemother Pharmacol, 45, 291, 10.1007/s002800050043 · DOI · Paper page
  8. Bradford, 2011, Capecitabine in the management of colorectal cancer, Cancer Manag Res, 3, 79
  9. Koukourakis, 2010, Capecitabine for locally advanced and metastatic colorectal cancer: a review, World J Gastrointest Oncol, 15, 311, 10.4251/wjgo.v2.i8.311 · DOI
  10. WalkoC, 2005, Capecitabine: a review, Clin Ther, 27, 23, 10.1016/j.clinthera.2005.01.005 · DOI
  11. Park, 2008, Controlled release of donepezil intercalated in smectite clays, Int J Pharma, 359, 198, 10.1016/j.ijpharm.2008.04.012 · DOI
  12. Sun, 2008, Multifunctional poly (D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer, Biomaterials, 29, 475, 10.1016/j.biomaterials.2007.09.038 · DOI · Paper page
  13. Dong, 2005, Poly (D,L -lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs, Biomaterials, 26, 6068, 10.1016/j.biomaterials.2005.03.021 · DOI
  14. Feng, 2009, Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel, Biomaterials, 30, 3297, 10.1016/j.biomaterials.2009.02.045 · DOI
  15. Kevadiya, 2010, Layered bionanocomposites as carrier for procainamide, Int J Pharma, 388, 280, 10.1016/j.ijpharm.2010.01.002 · DOI
  16. Joshi, 2012, Confinement and controlled release of quinine on chitosan–montmorillonite bionanocomposites, J Polym Sci Part A: Polym Chem, 50, 423, 10.1002/pola.25046 · DOI
  17. Joshi, 2010, Design and evaluation of controlled drug delivery system of buspirone using inorganic layered clay mineral, Micropor Mesopor Mater, 132, 526, 10.1016/j.micromeso.2010.04.003 · DOI
  18. Karin, 2003, A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells, BMC Cancer, 3, 1471
  19. Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65, 55, 10.1016/0022-1759(83)90303-4 · DOI · Paper page
  20. Ohkawa, 1979, Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction, Anal Biochem, 95, 351, 10.1016/0003-2697(79)90738-3 · DOI
  21. Kakkar, 1984, A modified spectrophotometric assay of superoxide dismutase, Ind J Biochem Biophysics, 4, 130
  22. Sedlak, 1968, Estimation of total protein-bound and non-protein sulphydryl groups in tissue with Ellman’s reagent, Anal Biochem, 25, 192, 10.1016/0003-2697(68)90092-4 · DOI
  23. Levine, 2000, Determination of carbonyl groups in oxidized proteins, Methods Mol Biol, 99, 15
  24. Pani Kumar, 2011, Development of validated stability indicating RP-HPLC Method for the estimation of capecitabine in pure and pharmaceutical formulations, Int J Res Pharma Biomed Sci, 2, 175
  25. Meloun, 2011, Determination of the thermodynamic dissociation constant of capecitabine using spectrophotometric and potentiometric titration data, J Chem Thermodyn, 43, 930, 10.1016/j.jct.2011.01.012 · DOI
  26. Agnihotri, 2006, Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine, Int J Pharma, 324, 103, 10.1016/j.ijpharm.2006.05.061 · DOI
  27. Wolf, 2006, The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction, Biochim Biophys Acta, 1760, 267, 10.1016/j.bbagen.2005.10.012 · DOI
  28. Alexandre, 2006, Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir, J Natl Cancer Inst, 98, 236, 10.1093/jnci/djj049 · DOI
  29. Conklin, 2004, Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness, Integr Cancer Therapies, 3, 294, 10.1177/1534735404270335 · DOI · Paper page
  30. Sun, 2011, Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents, J Pharmacol Exper Therapy, 338, 775, 10.1124/jpet.111.183533 · DOI

Cited by

Sorted by citations

See all 25

Metadata

Authors
Kevadiya, B. D., Chettiar, S. S., Rajkumar, S., Bajaj, H. C., Brahmbhatt, H., Chaudhari, J. C., Thumbar, R. P., Jhala, D., & Rao, M. V.
Venue
Composites Science and Technology
Publisher
Elsevier BV
Published
2014-01
Volume
90
Pages
193-201
ISSN
0266-3538
DOI
10.1016/j.compscitech.2013.11.003
Cited by
25
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review